Table 2 Correlation between specific mutation and recurrence risk in T4 well differentiated thyroid cancer.
From: Molecular Profile of Locally Aggressive Well Differentiated Thyroid Cancers
Mutation Positive, estimated 3-year recurrence rate | Mutation Negative, estimated 3-year recurrence rate | p-value | |
|---|---|---|---|
BRAF V600E positive (n = 7) | 47.37% | 0.00% | p = 0.04* |
TERT positive (n = 2) | 50.00% | 19.70% | p = 0.22 |
BRAF and TERT positive (n = 12) | 58.30% | 16.48% | p = 0.05* |
